APPLICATION
ANDA213267
TYPE
ANDA
ORIGINAL APPROVAL
2023-04-27
LATEST ACTION
2026-04-24
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription, Discontinued
Products
THALIDOMIDEPrescription
THALIDOMIDE 100MG · CAPSULE · ORAL
THALIDOMIDEDiscontinued
THALIDOMIDE 150MG · CAPSULE · ORAL
THALIDOMIDEPrescription
THALIDOMIDE 200MG · CAPSULE · ORAL
THALIDOMIDEPrescription
THALIDOMIDE 50MG · CAPSULE · ORAL
Approval history
2026-04-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.